Galmed Pharmaceuticals Ltd.
GLMD
$0.52
-$0.01-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.12M | -10.31M | -8.70M | -8.72M | -7.35M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 74.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.25M | 3.08M | 2.59M | 2.69M | 2.21M |
| Change in Net Operating Assets | 183.00K | 912.00K | -165.00K | 569.00K | -151.00K |
| Cash from Operations | -7.68M | -6.32M | -6.28M | -5.47M | -5.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.99M | -3.38M | -7.25M | -7.74M | -1.77M |
| Cash from Investing | -2.99M | -3.38M | -7.25M | -7.74M | -1.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.51M | 9.03M | 8.29M | 16.34M | 10.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.51M | 9.03M | 8.29M | 16.34M | 10.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.16M | -664.00K | -5.24M | 3.13M | 3.31M |